Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring
- 24 June 2003
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 794 (1) , 35-47
- https://doi.org/10.1016/s1570-0232(03)00393-3
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Cytochrome P450 2D6 Deficiency and its Clinical Relevance in a Patient Treated with RisperidonePharmacopsychiatry, 2002
- Effect of glucose on antipsychotic drug-induced changes in dopamine neuronal activityEuropean Journal of Pharmacology, 2001
- Possible Relationship between Combined Plasma Concentrations of Risperidone plus 9-Hydroxyrisperidone and Extrapyramidal SymptomsNeuropsychobiology, 2001
- Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone During Combined Treatment With ParoxetineTherapeutic Drug Monitoring, 2001
- Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patientsActa Psychiatrica Scandinavica, 2000
- Venlafaxine Serum Levels and CYP2D6 GenotypeTherapeutic Drug Monitoring, 2000
- Is Therapeutic Drug Monitoring a Case for Optimizing Clinical Outcome and Avoiding Interactions of the Selective Serotonin Reuptake Inhibitors?Therapeutic Drug Monitoring, 2000
- Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neurolepticsPsychopharmacology, 2000
- Haloperidol plasma levels and clinical response: a therapeutic window relationshipAmerican Journal of Psychiatry, 1992
- The Relationship Between Antidepressant Response and Tricyclic Antidepressant Plasma ConcentrationsClinical Pharmacokinetics, 1987